Supernus Pharmaceuticals, Inc. (SUPN)

49.86 -1.48 (-2.88%) USD  |  NASDAQ  |  Feb 12, 16:00
49.86 0.00 (0.00%) After-Hours: 16:48
More

Supernus Pharmaceuticals Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Moderna, Inc. Upgrade